Rapport Therapeutics (RAPP) Plunges 5.07% After Reaching 2025 High

Generado por agente de IAAinvest Movers Radar
viernes, 11 de julio de 2025, 6:45 pm ET1 min de lectura
RAPP--

Rapport Therapeutics (RAPP) shares experienced a significant decline, dropping by 5.07% today. The stock price reached its highest level since February 2025, with an intraday gain of 2.08%.

The strategy of buying RAPPRAPP-- shares after they reach a recent high and selling them one week later delivered moderate returns but came with significant volatility and risk. The strategy’s CAGR was 1.94% with an excess return of 102.09% relative to the benchmark, which had a return of -100.00%. However, the strategy had a maximum drawdown of 0.00% and a Sharpe ratio of 0.02, indicating it managed risk well but offered conservative returns.

On July 11, 2025, there was no relevant information regarding the causes of changes in Rapport TherapeuticsRAPP-- (RAPP) stock price according to the criteria provided.


Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios